Research Topics
| Jon EbbertSummaryAffiliation: Mayo Clinic Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Fat depots, free fatty acids, and dyslipidemiaJon O Ebbert
Division of Primary Care Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Nutrients 5:498-508. 2013..In the current review, we will explore the relationship between adipose tissue, body fat depots, and FFA metabolism...
Comparative effectiveness of the nicotine lozenge and tobacco-free snuff for smokeless tobacco reductionJon O Ebbert
Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Addict Behav 38:2140-5. 2013..12%, one-tailed p=.615). The 4-mg nicotine lozenge and the tobacco-free snuff both appear to be effective and comparable for reducing ST use among ST users not ready to quit in the next 30 days...
A comparison of three smokeless tobacco dependence measuresJon O Ebbert
Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
Addict Behav 37:1271-7. 2012..The use of the scales is discussed in terms of clinical usefulness and how each scale might assess differing aspects of tobacco dependence...
Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individualsEdward J Mills
Faculty of Health Sciences, University of Ottawa, Ottawa, Canada
Tob Induc Dis 8:8. 2010..Although expectations of mild adverse effects have been observed to be independent predictors of reduced motivation to use NRT, adverse effects associated with NRT have not been precisely quantified...
Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trialRichard D Hurt
Nicotine Dependence Center, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
J Negat Results Biomed 10:1. 2011....
Nicotine percentage replacement among smokeless tobacco users with nicotine patchJon O Ebbert
Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA
Drug Alcohol Depend 89:223-6. 2007..We conclude that the use of 42 mg/day nicotine patch therapy is safe and should be considered as initial therapy in the clinical setting among ST users who use > or =3 cans/week...
A randomized clinical trial of nicotine lozenge for smokeless tobacco useJon O Ebbert
Mayo Clinic College of Medicine Rochester, MN 55905, USA
Nicotine Tob Res 11:1415-23. 2009..Smokeless tobacco (ST) use is associated with adverse health consequences, and effective treatments are needed. Pilot data suggest that 4-mg nicotine lozenge decreases tobacco craving and nicotine withdrawal symptoms among ST users...
The Fagerström Test for Nicotine Dependence-Smokeless Tobacco (FTND-ST)Jon O Ebbert
Nicotine Research Program, Primary Care Internal Medicine, Department of Internal Medicine, Mayo Clinic 200 1st Street Southwest, Rochester, MN 55905, USA
Addict Behav 31:1716-21. 2006..Development and refinement of nicotine dependence measures for ST users are essential steps in order to advance the field of ST research...
Predictors of smokeless tobacco initiation in a young adult military cohortJon O Ebbert
Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
Am J Health Behav 30:103-12. 2006..To identify predictors of smokeless tobacco (ST) initiation among young adults...
Clinical utility of varenicline for smokers with medical and psychiatric comorbidityJon O Ebbert
Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
Int J Chron Obstruct Pulmon Dis 4:421-30. 2009..In conjunction with behavioral interventions and clinical monitoring for potential side effects, varenicline offers great hope for reducing smoking-attributable death and disability...
A pilot study of mailed nicotine lozenges with assisted self-help for the treatment of smokeless tobacco usersJon O Ebbert
Mayo Clinic College of Medicine, 200 1st Street Southwest, Rochester, MN 55905, USA
Addict Behav 35:522-5. 2010..We conclude that the mailing of nicotine lozenges to ST users is a feasible and safe strategy the efficacy of which needs to be evaluated...
The missing link in tobacco controlJon O Ebbert
Nicotine Dependence Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
CMAJ 179:123-4. 2008
Nicotine lozenges for the treatment of smokeless tobacco useJon O Ebbert
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Nicotine Tob Res 9:233-40. 2007..Future phase III clinical trials investigating the efficacy of nicotine lozenges are warranted...
Varenicline and bupropion sustained-release combination therapy for smoking cessationJon O Ebbert
Mayo Clinic College of Medicine, 200 1st Street Southwest, Rochester, MN 55905, USA
Nicotine Tob Res 11:234-9. 2009..Combination pharmacotherapy with these agents may increase long-term smoking abstinence rates above what is observed with single-agent therapy...
Treating tobacco dependence: review of the best and latest treatment optionsJon O Ebbert
Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Thorac Oncol 2:249-56. 2007..We review the currently available pharmacologic approaches to the treatment of tobacco dependence...
Tobacco use quitline enrollment through dental practices: a pilot studyJon O Ebbert
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
J Am Dent Assoc 138:595-601. 2007..Opportunities exist for dental providers to help patients who smoke by enrolling them in tobacco use quitlines. The authors conducted a pilot study to investigate whether such referrals were feasible and effective...
Combination treatment with varenicline and nicotine replacement therapyJon O Ebbert
Mayo Clinic College of Medicine, 200 1st Street Southwest, Rochester, MN 55905, USA
Nicotine Tob Res 11:572-6. 2009..A paucity of data exists regarding the safety and effectiveness of combination treatment with varenicline and nicotine replacement therapy (NRT)...
Association between respiratory tract diseases and secondhand smoke exposure among never smoking flight attendants: a cross-sectional surveyJon O Ebbert
Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Environ Health 6:28. 2007..We undertook this study to evaluate the association between accumulated flight time in smoky airplane cabins and respiratory tract diseases in a cohort of never smoking flight attendants...
Emerging drugs for the treatment of tobacco dependenceJon O Ebbert
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Expert Opin Emerg Drugs 14:23-32. 2009..Tobacco use is a worldwide epidemic expected to cause 10 million annual deaths by 2020 globally. Newer pharmacotherapy increases the specificity of tobacco dependence treatment by affecting receptors mediating nicotine effects...
Predictors of smokeless tobacco abstinenceJon O Ebbert
Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Am J Health Behav 32:735-40. 2008..To investigate predictors of tobacco abstinence among smokeless tobacco (ST) users...
Combination pharmacotherapy for stopping smoking: what advantages does it offer?Jon O Ebbert
Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Drugs 70:643-50. 2010..Available data suggests that combination therapy may increase abstinence rates compared with monotherapy. However, the cost effectiveness of this approach has not been clearly demonstrated...
Smokeless tobacco reduction with the nicotine lozenge and behavioral interventionJon O Ebbert
Mayo Clinic, Rochester, MN 55905, USA
Nicotine Tob Res 12:823-7. 2010..Studies have evaluated smoking reduction with nicotine replacement therapy to reduce tobacco exposure and facilitate abstinence among cigarette smokers, but none have evaluated a reduction approach in smokeless tobacco (ST) users...
A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United StatesJon O Ebbert
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Nicotine Tob Res 13:820-6. 2011..We have conducted a pilot study to obtain preliminary evidence of efficacy of varenicline for the treatment of ST users in Midwestern United States...
Searching the medical literature using PubMed: a tutorialJon O Ebbert
Division of Community Internal Medicine, Mayo Clinic, MN 55905, USA
Mayo Clin Proc 78:87-91. 2003..The purpose of this article is to assist clinicians in the development of the basic skills required to use PubMed to make informed clinical decisions...
Pharmacological interventions for the treatment of smokeless tobacco useJon O Ebbert
Mayo Clinic, Rochester, MN 55905, USA
CNS Drugs 26:1-10. 2012..Additional investigations of higher dose NRT and combination pharmacotherapy are needed to advance the treatment of SLT users...
Treatments for spit tobacco use: a quantitative systematic reviewJon O Ebbert
Division of Community Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Addiction 98:569-83. 2003..Health-care providers have neither evidence summaries nor evidence-based guidelines to assist them in treating patients who use spit tobacco...
Evaluation of a student-run smoking cessation clinic for a medically underserved populationLindsay E Lough
Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA
BMC Res Notes 4:55. 2011..abstract:..
Cotinine as a biomarker of systemic nicotine exposure in spit tobacco usersJon O Ebbert
Department of Internal Medicine, Division of Community Medicine, Mayo Clinic, Rochester, MN 55905, USA
Addict Behav 29:349-55. 2004....
Residential treatment for smokeless tobacco use: a case seriesJon O Ebbert
Nicotine Dependence Center, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
J Subst Abuse Treat 26:261-7. 2004..More research is needed to replicate our findings and determine if comparable abstinence rates can be achieved with outpatient ST treatment programs using similar behavioral and pharmacotherapies...
Smokeless tobacco: an emerging addictionJon O Ebbert
Department of Medicine, Mayo Clinic College of Medicine, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA
Med Clin North Am 88:1593-605. 2004..Clinical treatment of ST users requires an understanding of the unique characteristics of ST. This article reviews ST products, epidemiology, pharmacology, health risks, and treatment approaches...
Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco usersJon O Ebbert
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Nicotine Tob Res 9:43-52. 2007..High-dose nicotine patch therapy is safe and well tolerated in this population of tobacco users...
The association of alcohol consumption with coronary heart disease mortality and cancer incidence varies by smoking historyJon O Ebbert
Nicotine Research Center, Division of Community Internal Medicine, Rochester, MN 55905, USA
J Gen Intern Med 20:14-20. 2005..To evaluate the effect of alcohol on coronary heart disease (CHD), cancer incidence, and cancer mortality by smoking history...
Portion control for the treatment of obesity in the primary care settingRebecca L Kesman
Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
BMC Res Notes 4:346. 2011..abstract:..
A survey of characteristics of smokeless tobacco users in a treatment programJon O Ebbert
Mayo Clinic of Medicine, Rochester, MN 55905, USA
Am J Health Behav 29:25-35. 2005..To determine the characteristics and outcomes of smokeless tobacco (ST) users receiving interventions in an outpatient tobacco-dependence treatment program...
A pilot study to assess smokeless tobacco use reduction with vareniclineJon O Ebbert
Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Nicotine Tob Res 12:1037-40. 2010..Similarly, a reduction strategy may reduce ST exposure and increase ST abstinence rates among ST users not interested in quitting...
Bupropion SR for the treatment of smokeless tobacco useLowell C Dale
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Drug Alcohol Depend 90:56-63. 2007..We conducted a multicenter, randomized, double-blind, placebo-controlled, clinical trial to assess the efficacy and safety of bupropion SR for tobacco abstinence among ST users...
Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot studyAmit Sood
General Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Nicotine Tob Res 11:1479-84. 2009..Varenicline is the most effective medication for smoking cessation but does not prevent weight gain. Combining sibutramine and varenicline may facilitate smoking abstinence if weight gain is attenuated...
No interaction of body mass index and smoking on diabetes mellitus risk in elderly womenMichael W Cullen
Nicotine Dependence Center, Primary Care Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Prev Med 48:74-8. 2009..We sought to assess the interaction of smoking and body mass index (BMI) on diabetes risk...
Gender differences in self-reported use, perceived efficacy, and interest in future use of nicotine-dependence treatments: A cross-sectional survey in adults at a tertiary care center for nicotine dependenceSujata Narayanan
Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Gend Med 6:362-8. 2009....
Interventions for tobacco cessation in the dental settingAlan B Carr
Department of Dental Specialities, Mayo Clinic, Rochester
Cochrane Database Syst Rev 6:CD005084. 2012..Tobacco use has significant adverse effects on oral health. Oral health professionals in the dental office or community setting have a unique opportunity to increase tobacco abstinence rates among tobacco users...
Feasibility of a telephone-based intervention for support persons to help smokers quit: a pilot studyChristi A Patten
Department of Psychiatry and Psychology and Behavioral Health Research Program, Mayo Clinic College of Medicine, Charlton 6 273, 200 First Street Southwest, Rochester, MN 55905, USA
Nicotine Tob Res 11:427-32. 2009..Nonsmokers have a potentially supportive role in tobacco cessation efforts. The present study examined the feasibility, acceptability, and potential efficacy of a telephone-based intervention for nonsmoking support persons...
Open doorway to truth: legacy of the Minnesota tobacco trialRichard D Hurt
Division of Primary Care Internal Medicine, Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 84:446-56. 2009....
"Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in ChinaMonique E Muggli
Mayo Clinic, Rochester, Minnesota, USA
PLoS Med 5:1729-69. 2008..Internal tobacco industry documents show that transnational tobacco companies (TTCs) have pursued a multifaceted strategy for undermining the adoption of restrictions on smoking in many countries...
Feasibility of an exercise counseling intervention for depressed women smokersKristin S Vickers
Department of Psychiatry and Psychology, Mayo Clinic Rochester, 200 First Street South West, Rochester, MN 55905, USA
Nicotine Tob Res 11:985-95. 2009..This pilot study investigated the feasibility of an exercise intervention for depressed female smokers (Center for Epidemiological Studies Depression Scale [CES-D] score > or =16)...
Treating tobacco dependence in light of the 2008 US Department of Health and Human Services clinical practice guidelineJ Taylor Hays
Division of General Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 84:730-5; quiz 735-6. 2009..This article briefly reviews the major updates and recommendations from the new guideline and highlights its practical clinical applications...
Treating tobacco dependence in a medical settingRichard D Hurt
Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
CA Cancer J Clin 59:314-26. 2009..The effective treatment of tobacco dependence frequently requires tailoring, and often intensifying, interventions (both counseling and pharmacotherapy) to meet the needs of the individual patient...
The association of alcohol consumption with tobacco use in Black and White college studentsSteven C Ames
Mayo Clinic, Jacksonville Florida, USA
Subst Use Misuse 45:1230-44. 2010..Racial and gender differences are highlighted. This study was funded by Mayo Clinic. The study's limitations were noted...
Legislating tolerance: Spain's national public smoking lawMonique E Muggli
Mayo Clinic Nicotine Research Program, 127 Orlin Ave SE, Rochester, MN 55414, USA
Tob Control 19:24-30. 2010..In doing so, Spain's smoke-free public places law would be better aligned with the Framework Convention on Tobacco Control...
Residential treatment compared with outpatient treatment for tobacco use and dependenceJ Taylor Hays
Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 86:203-9. 2011..To compare the effectiveness of outpatient vs residential treatment for tobacco dependence in a large referral practice...
A randomized clinical trial of St. John's wort for smoking cessationAmit Sood
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
J Altern Complement Med 16:761-7. 2010..St. John's wort (SJW) is a widely used herbal supplement. The predominant mechanism(s) accounting for the activity of SJW in vivo are, however, unclear. The purpose of this study was to investigate the efficacy of SJW for smoking cessation...
Cochrane systematic reviews in acupuncture: methodological diversity in database searchingAmit Sood
Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
J Altern Complement Med 11:719-22. 2005..Results from these trials have been synthesized in systematic reviews. A well-designed systematic review provides the highest level of evidence for establishing the efficacy of a clinical intervention...
The relationship between caffeine and blood pressure in preadolescent African American girlsJagadeshwar G Reddy
Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Ethn Dis 18:283-8. 2008..The primary objective of this study was to assess the cross-sectional relationship between caffeine intake and blood pressure in 8- to 10-year-old African American girls who eat an unrestricted diet...
Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative periodDavid J Rosenman
Knowledge and Encounter Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Hosp Med 3:319-25. 2008..This practice variation reflects uncertainty regarding the risks and benefits of either approach...
Complementary treatments for tobacco cessation: a surveyAmit Sood
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Nicotine Tob Res 8:767-71. 2006..The high level of interest in CAM among tobacco users underscores the need to conduct further research in this field...
Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: a reviewPing Yang
Division of Epidemiology and Cancer Center, Nicotine Dependence Center, and Department of Molecular Pharmacology and Experimental Therapeutics, Rochester, MN 55905, USA
J Clin Oncol 24:1761-9. 2006..The potential application of glutathione system polymorphic genetic markers in identifying patients who may respond favorably, selecting effective antitumor drugs, and balancing drug efficacy and toxicity are discussed...
Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonatesRichard D Hurt
Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
J Matern Fetal Neonatal Med 17:281-9. 2005..To determine the concentration of nicotine and cotinine in maternal blood and neonatal cord blood among pregnant Alaska Native women and to assess the neonates for neurobehavioral effects...
Preventing lung cancer by stopping smokingRichard D Hurt
Nicotine Dependence Center, Division of Community Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
Clin Chest Med 23:27-36, vii. 2002..The use of these medications can be tailored to meet the patients needs and combinations of these medications can be used when appropriate. More intensive treatment, such as residential treatment, may be needed for more addicted smokers...
Motivation for stopping tobacco use among emergency department patientsMartin D Klinkhammer
Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA
Acad Emerg Med 12:568-71. 2005..These findings suggest that the development of new models for reinforcing tobacco-use interventions initiated in the ED deserve exploration, such as linking them to a tobacco quitline...
Survey assessment of personal digital assistant use among trainees and attending physiciansThomas G McLeod
Division of Community Internal Medicine, Department of Biostatistics, Mayo Clinic, Rochester, MN 55905, USA
J Am Med Inform Assoc 10:605-7. 2003..These findings may reflect differences in the information needs and work roles of learners and experienced physicians. Such factors may be important considerations for the development and implementation of institutional PDA resources...
Bupropion sustained release for treatment of tobacco dependenceJ Taylor Hays
Division of General Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
Mayo Clin Proc 78:1020-4; quiz 1024. 2003....
Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefitsJ Taylor Hays
Mayo Nicotine Dependence Center, Rochester, Minnesota 55905, USA
CNS Drugs 17:71-83. 2003..Recent postmarketing surveillance reports have raised safety concerns about bupropion, although no causal relationship between bupropion and the reported serious adverse events or death has been established...
Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot studyLowell C Dale
Division of Community Internal Medicine, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
Nicotine Tob Res 4:267-74. 2002..2 +/- 5.0 kg in the placebo group (p = 0.49). Bupropion may increase abstinence rates in ST users and appears to attenuate weight gain during ST abstinence. Larger randomized, controlled trials of bupropion for ST users are needed...
Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profilesThomas P Moyer
Drug Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA
Clin Chem 48:1460-71. 2002..Absence of nicotine metabolites and anabasine can be used to document abstinence from tobacco products, an indicator of treatment success...
Clinicians' guide to new tools and features of PubMedDenise M Dupras
Division of Primary Care Internal Medicine, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 82:480-3; quiz 484. 2007..This article is the third in a Mayo Clinic Proceedings series designed specifically to help clinicians unlock the tools and information available through this valuable resource...
Efficacy and safety of varenicline for smoking cessationJ Taylor Hays
Nicotine Dependence Center, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Med 121:S32-42. 2008..As the newest agent approved for smoking cessation, the mechanism of action, efficacy, and safety of varenicline...
Gabapentin for smoking cessation: a preliminary investigation of efficacyAmit Sood
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Nicotine Tob Res 9:291-8. 2007..Our results suggest that gabapentin may increase smoking abstinence. An adequately powered randomized clinical trial assessing different doses of this drug against a placebo would be the reasonable next step...
Differences among Black and White young adults on prior attempts and motivation to help a smoker quitChristi A Patten
Department of Psychiatry and Psychology and Behavioral Health Research Program, Mayo Clinic Rochester, Rochester, MN 55901, United States
Addict Behav 33:496-502. 2008..Tobacco control efforts could focus on optimizing these supportive behaviors as well as expressed motivation and interest in helping a smoker to quit among young adult nonsmokers...
Waking a sleeping giant: the tobacco industry's response to the polonium-210 issueMonique E Muggli
Nicotine Research Program, Mayo Clinic, Rochester, MN 55905, USA
Am J Public Health 98:1643-50. 2008..Tobacco companies continue to minimize their knowledge about polonium-210 in cigarettes in smoking and health litigation. Cigarette packs should carry a radiation-exposure warning label...
Development of a telephone-based intervention for support persons to help smokers quitChristi A Patten
Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55901, USA
Psychol Health Med 13:17-28. 2008..Results indicate that the telephone-based intervention was feasible and acceptable to participants. The intervention was refined based on participant and counselor feedback and will be subsequently tested in a randomized pilot trial...
Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot studyJ Taylor Hays
Mayo Clinic, Nicotine Dependence Center, Rochester, Minnesota 55905, USA
J Subst Abuse Treat 40:102-7. 2011..No serious adverse events were reported. Varenicline may be a useful aid for treating tobacco dependence among smokers who are in stable recovery from alcohol dependence. Further study of this treatment is warranted...
Gender differences among smokers receiving interventions for tobacco dependence in a medical settingIvana T Croghan
Mayo Clinic, Nicotine Dependence Center, 200 First St, SW, Rochester, Minnesota 55905, United States
Addict Behav 34:61-7. 2009..The purpose of this study was to assess differences between women and men receiving treatment for tobacco dependence through a clinical treatment program...
Adverse effects and tolerability of medications for the treatment of tobacco use and dependenceJ Taylor Hays
Mayo Clinic Nicotine Dependence Center, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Drugs 70:2357-72. 2010..Given these factors, the benefit : risk ratio is strongly in favour of pharmacotherapy for tobacco dependence treatment in virtually all smokers who are motivated to quit...
Interventions for smokeless tobacco use cessationJon Ebbert
Department of Primary Care Internal Medicine, Mayo Clinic, 200 1st Street Southwest, Rochester, Minnesota, USA, 55905
Cochrane Database Syst Rev 2:CD004306. 2011..Use of smokeless tobacco (ST) can lead to nicotine addiction and long-term use can lead to health problems including periodontal disease, cancer, and cerebrovascular and cardiovascular disease...
Zebrafish for the study of the biological effects of nicotineEric W Klee
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
Nicotine Tob Res 13:301-12. 2011..When combined with a battery of molecular-genetic tools and behavioral assays, these attributes enable studies to be conducted that are not practical using traditional animal models...
A multidimensional workshop using human cadavers to teach bedside proceduresAmy S Oxentenko
Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Teach Learn Med 15:127-30. 2003..More research needs to be done to determine if this workshop increases the number and proficiency of bedside diagnostic procedures performed by residents...
Smokeless tobacco reduction: preliminary study of tobacco-free snuff versus no snuffDorothy K Hatsukami
University of Minnesota, Tobacco Use Research Center, Minneapolis, MN 55414, USA
Nicotine Tob Res 10:77-85. 2008....
Treatment of tobacco dependenceMichael V Burke
Nicotine Dependence Center, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 83:479-83; quiz 483-4. 2008..Because tobacco dependence is characterized by relapses and remissions, clinicians should be ready to engage smokers and reengage relapsed smokers with options for new medication strategies and additional counseling resources...
Tobacco use outcomes among patients with lung cancer treated for nicotine dependenceLisa Sanderson Cox
Nicotine Research Center, Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
J Clin Oncol 20:3461-9. 2002..CONCLUSION: The results suggest that nicotine dependence treatment is effective for patients with a diagnosis of lung cancer. The majority of lung cancer patients were motivated to stop smoking...
Re: chronic disease mortality in a cohort of smokeless tobacco usersJon O Ebbert
Am J Epidemiol 158:1021; author reply 1021-2. 2003
Prevalence of alternative forms of tobacco use in a population of young adult military recruitsMark W Vander Weg
Center for Research in the Implementation of Innovative Strategies in Practice CRIISP, VA Medical Center, 601 Highway 6 West, Mail Stop 152, Iowa City, IA 52246, United States
Addict Behav 33:69-82. 2008..001). Patterns of use also differed according to other demographic characteristics including race, ethnicity, age, and income. Implications for surveillance and tobacco control efforts are discussed...
Trial design: blood pressure control and weight gain prevention in prehypertensive and hypertensive smokers: the treatment and prevention studyMark W Vander Weg
Iowa City VA Medical Center, Center for Research in the Implementation of Innovative Strategies in Practice CRIISP, University of Iowa Dept of Internal Medicine, Iowa City, IA 52246, USA
Contemp Clin Trials 29:281-92. 2008..Intervention strategies that facilitate smoking cessation and modify adverse changes in body weight and BP are needed...
Measuring nicotine dependence among smokeless tobacco usersJanet L Thomas
University of Kansas Medical Center, Department of Preventive Medicine and Public Health, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA
Addict Behav 31:1511-21. 2006..493+/-246 ng/ml; P=0.042). Poor concordance was observed between the FTQ-ST and the DIS-IV in the assessment of nicotine dependence in ST users...
Iqmik: a form of smokeless tobacco used among Alaska nativesCaroline C Renner
Office of Alaska Native Health Research, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
Am J Health Behav 29:588-94. 2005..To describe a homemade form of smokeless tobacco known as Iqmik used among Alaska Natives residing in western Alaska...
Changing smokeless tobacco products new tobacco-delivery systemsDorothy K Hatsukami
Transdisciplinary Tobacco Use Research Center, University of Minnesota, Minneapolis, Minnesota 55414, USA
Am J Prev Med 33:S368-78. 2007....
Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer riskPing Yang
Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Chest 128:445-52. 2005..We conducted a case-control study to investigate whether genetic variations indicative of alpha(1)-antitrypsin deficiency (A1ATD) or an excess of neutrophil elastase modify lung cancer risk..
Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortalityAditya Bardia
Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
J Natl Cancer Inst 99:881-9. 2007..We evaluated associations between aspirin and nonaspirin NSAID use with cancer incidence and mortality stratified by smoking history in the Iowa Women's Health Study, a prospective cohort of postmenopausal women...
The relationship between cigarette smoking and quality of life after lung cancer diagnosisYolanda I Garces
Mayo Clinic, Charlton 6, 200 First Street SW, Rochester, MN 55905, USA
Chest 126:1733-41. 2004..CONCLUSION: The hypothesized relationship between smoking status and QOL was supported by this correlational study. Our findings suggest that persistent cigarette smoking after a lung cancer diagnosis negatively impacts QOL scores...
Methylprednisolone, valacyclovir, or both for vestibular neuritisAmit Sood
N Engl J Med 351:2344-5; author reply 2344-5. 2004
A qualitative assessment of 1st-year internal medicine residents' perceptions of evidence-based clinical decision makingVictor M Montori
Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Teach Learn Med 14:114-8. 2002..Further research is needed to better understand the link between decision-making style and evidence-based medicine...
Using advanced search tools on PubMed for citation retrievalAmit Sood
Division of General Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
Mayo Clin Proc 79:1295-9; quiz 1300. 2004..In this article, we build on this foundation and present advanced search tools designed to assist clinicians in performing efficient and focused literature searches...
Research Grants
- Evaluating Nicotine Lozenges for Treatment of Smokeless Tobacco AddictionJon Ebbert; Fiscal Year: 2009..No drug therapies have been shown to be effective for helping smokeless tobacco users quit for good. The purpose of this study is to test drugs that can be used to help smokeless tobacco users quit for good. ..
- Evaluating Nicoting Lozenges for Treatment of Smokeless Tobacco AddictionJon Ebbert; Fiscal Year: 2007..No drug therapies have been shown to be effective for helping smokeless tobacco users quit for good. The purpose of this study is to test drugs that can be used to help smokeless tobacco users quit for good. ..
- Brief Dental Office Intervention with Tobacco QuitlineJon Ebbert; Fiscal Year: 2005..S. adult population smoking; and 3) 75% of smokers quitting for at least one day or longer because they are trying to quit. ..
- High Dose Nicotine Patch Therapy for Spit Tobacco UsersJon Ebbert; Fiscal Year: 2004..Our goal is to reduce the prevalence of ST use and decrease the incidence of oropharyngeal cancer through the development of effective treatment options for ST users. ..
- Combination Therapy with Varenicline and Bupropion for Smoking CessationJon O Ebbert; Fiscal Year: 2010..Combining medications together may increase the long-term smoking quit rates and decrease the death and disability associated with cigarette smoking. ..
